J. L. Vildé

1.6k total citations
39 papers, 1.0k citations indexed

About

J. L. Vildé is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, J. L. Vildé has authored 39 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 11 papers in Infectious Diseases and 9 papers in Virology. Recurrent topics in J. L. Vildé's work include Pneumocystis jirovecii pneumonia detection and treatment (8 papers), HIV Research and Treatment (8 papers) and Toxoplasma gondii Research Studies (6 papers). J. L. Vildé is often cited by papers focused on Pneumocystis jirovecii pneumonia detection and treatment (8 papers), HIV Research and Treatment (8 papers) and Toxoplasma gondii Research Studies (6 papers). J. L. Vildé collaborates with scholars based in France, Switzerland and Australia. J. L. Vildé's co-authors include J Breton-Gorius, C. Leport, Catherine Leport, C Marche, Sophie Matheron, Christine Katlama, F. Raffi, Adrien G. Saimot, C Vedrenne and D Y Mason and has published in prestigious journals such as Annals of Internal Medicine, Clinical Infectious Diseases and Annals of Neurology.

In The Last Decade

J. L. Vildé

38 papers receiving 979 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. L. Vildé France 18 553 320 235 204 140 39 1.0k
C Marche France 19 668 1.2× 412 1.3× 244 1.0× 448 2.2× 182 1.3× 82 1.5k
Eskild Petersen United States 17 708 1.3× 427 1.3× 200 0.9× 81 0.4× 108 0.8× 31 1.4k
Kathleen Hayes United States 21 894 1.6× 324 1.0× 80 0.3× 366 1.8× 85 0.6× 77 1.7k
Örjan Strannegård Sweden 23 407 0.7× 404 1.3× 84 0.4× 450 2.2× 57 0.4× 54 1.5k
Robin Saltzman United States 15 1.1k 2.1× 242 0.8× 167 0.7× 162 0.8× 66 0.5× 18 1.4k
M. Denis France 23 467 0.8× 532 1.7× 117 0.5× 127 0.6× 180 1.3× 65 1.3k
D. Meillet France 17 185 0.3× 217 0.7× 113 0.5× 102 0.5× 52 0.4× 47 703
A. G. Saimot France 11 352 0.6× 254 0.8× 144 0.6× 297 1.5× 49 0.3× 21 763
K P McAdam United Kingdom 20 428 0.8× 500 1.6× 177 0.8× 23 0.1× 267 1.9× 37 1.2k
J. Craske United Kingdom 17 727 1.3× 333 1.0× 41 0.2× 287 1.4× 42 0.3× 36 1.4k

Countries citing papers authored by J. L. Vildé

Since Specialization
Citations

This map shows the geographic impact of J. L. Vildé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. L. Vildé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. L. Vildé more than expected).

Fields of papers citing papers by J. L. Vildé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. L. Vildé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. L. Vildé. The network helps show where J. L. Vildé may publish in the future.

Co-authorship network of co-authors of J. L. Vildé

This figure shows the co-authorship network connecting the top 25 collaborators of J. L. Vildé. A scholar is included among the top collaborators of J. L. Vildé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. L. Vildé. J. L. Vildé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Breton, Guillaume, et al.. (2005). Patients schizophrènes infectés par le VIH traités par antirétroviraux. La Presse Médicale. 34(6). 431–437. 4 indexed citations
2.
Benvéniste, Olivier, Pascale Longuet, Xavier Duval, et al.. (1999). Two Episodes of Acute Renal Failure, Rhabdomyolysis, and Severe Hepatitis in an AIDS Patient Successively Treated with Ritonavir and Indinavir. Clinical Infectious Diseases. 28(5). 1180–1181. 19 indexed citations
3.
Mainardi, Jean‐Luc, F. Lacassin, F. W. Goldstein, et al.. (1998). Low rate of Clostridium difficile colonization in ambulatory and hospitalized HIV-infected patients in a hospital unit: a prospective survey. Journal of Infection. 37(2). 108–111. 8 indexed citations
4.
Gérard, Laurence, C. Leport, Philippe Flandre, et al.. (1997). Cytomegalovirus (CMV) Viremia and the CD4+ Lymphocyte Count as Predictors of CMV Disease in Patients Infected with Human Immunodeficiency Virus. Clinical Infectious Diseases. 24(5). 836–840. 48 indexed citations
5.
Carré, Nicolas, Faroudy Boufassa, Christiane Deveau, et al.. (1996). High risk of HIV disease progression after infection through a sexual partner with AIDS. AIDS. 10(1). 77–80. 17 indexed citations
6.
Anglaret, Xavier, J. Saba, C. Perronne, et al.. (1994). Empiric antituberculosis treatment: benefits for earlier diagnosis and treatment of tuberculosis. Tubercle and Lung Disease. 75(5). 334–340. 20 indexed citations
7.
Perronne, C., et al.. (1992). Should pulmonary tuberculosis be an AIDS-defining diagnosis in patients infected with HIV?. Tubercle and Lung Disease. 73(1). 39–44. 33 indexed citations
8.
Leport, C., et al.. (1991). Long-term follow-up of patients with AIDS on maintenance therapy for toxoplasmosis. European Journal of Clinical Microbiology & Infectious Diseases. 10(3). 191–193. 14 indexed citations
9.
Fernández-Martín, Julián, C. Leport, P. Morlat, et al.. (1991). Pyrimethamine-clarithromycin combination for therapy of acute Toxoplasma encephalitis in patients with AIDS. Antimicrobial Agents and Chemotherapy. 35(10). 2049–2052. 77 indexed citations
10.
Cooper, David A., Court Pedersen, F Aiuti, et al.. (1991). The efficacy and safety of zidovudine with or without acyclovir in the treatment of patients with AIDS-related complex. AIDS. 5(8). 933–944. 20 indexed citations
11.
Saïd, G., C. Lacroix, Catherine Goulon‐Goeau, et al.. (1991). Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: A clinical and pathological study. Annals of Neurology. 29(2). 139–146. 83 indexed citations
12.
Leport, Catherine, Olivier Goëau-Brissonnière, C. Lebrault, J. L. Vildé, & J. C. Pechèré. (1991). Mechanisms of Ceftriaxone Prophylaxis Against Late Bacteremic Vascular Graft Infection Caused by Staphylococcus aureus in a Dog Model. Annals of Vascular Surgery. 5(6). 500–505. 1 indexed citations
13.
Leport, C., François Raffi, & J. L. Vildé. (1988). Traitement de la toxoplasmose cerebrale au cours du SIDA. Médecine et Maladies Infectieuses. 18. 729–736. 4 indexed citations
14.
Raffi, F., et al.. (1988). Pseudomonas aeruginosa sepsis presenting as peripheral subcutaneous nodules. Report of 2 cases. Intensive Care Medicine. 14(4). 434–436. 2 indexed citations
15.
Leport, Catherine, F. Raffi, Sophie Matheron, et al.. (1988). Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. The American Journal of Medicine. 84(1). 94–100. 192 indexed citations
16.
Leport, C., et al.. (1987). Neuropathie périphérique en relation avec l'infection par le rétrovirus LAV/HTLV III. Etude clinique, anatomique et immunologique. Cinq observations.. La Presse Médicale. 16(2). 8 indexed citations
17.
Breton-Gorius, J, D Y Mason, D Buriot, J. L. Vildé, & C Griscelli. (1980). Lactoferrin deficiency as a consequence of a lack of specific granules in neutrophils from a patient with recurrent infections. Detection by immunoperoxidase staining for lactoferrin and cytochemical electron microscopy.. PubMed. 99(2). 413–28. 102 indexed citations
18.
Breton-Gorius, J, J Guichard, William Vainchenker, & J. L. Vildé. (1980). Ultrastructural and cytochemical changes induced by short and prolonged culture of human monocytes.. PubMed. 27(3). 289–301. 33 indexed citations
19.
20.
Vildé, J. L. & F Vildé. (1976). Nitroblue Tetrazolium Reduction by Human Macrophages: Studies in Chronic Granulomatous Disease. Advances in experimental medicine and biology. 73 PT-A. 139–149. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C Marche Breakdown of academic impact, for papers by Eskild Petersen Breakdown of academic impact, for papers by Kathleen Hayes Breakdown of academic impact, for papers by Örjan Strannegård Breakdown of academic impact, for papers by Robin Saltzman Breakdown of academic impact, for papers by M. Denis Breakdown of academic impact, for papers by D. Meillet Breakdown of academic impact, for papers by A. G. Saimot Breakdown of academic impact, for papers by K P McAdam Breakdown of academic impact, for papers by J. Craske
Rankless by CCL
2026